AzTrials
AzTrials

Anal Fistula SurgeryRAPPORTNCT07477496

Recurrence and Anal Fistula Patient Reported Outcomes Trial

An observational study of Anal Fistula Surgery and Anal Fistula, run by National and Kapodistrian University of Athens at 1 site in Greece.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Perianal fistulas are a chronic anorectal condition associated with significant morbidity, including pain, persistent discharge, infection, and impaired continence, all of which can substantially affect patients' quality of life. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Perianal fistula surgical repair
How many people
100 participants
Where
1 siteGreece
Study dates
1 Jan 2026to 1 Jan 2030
How long will I take part?
24 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study will enroll adult patients with cryptoglandular perianal fistulas who are scheduled for elective surgical repair. Participants will be free of inflammatory bowel disease and major anorectal resections, and they will be able to provide informed consent, complete validated patient-reported outcome measures, and comply with the scheduled 12-month follow-up protocol.

Who may be able to join

  • Age ≥ 18 years.
  • Clinically and/or radiologically confirmed perianal fistula (primary or recurrent).
  • Planned definitive surgical treatment (any sphincter-dividing or sphincter-preserving technique).
  • Ability to understand and complete study questionnaires.
  • Commitment to attend follow-up visits at 1, 3, 6, and 12 months (or to complete remote assessments).
  • Signed written informed consent.

Who cannot join

  • Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis).
  • Active perianal sepsis requiring emergency drainage after enrolment and before definitive surgery.
  • Prior abdominoperineal resection or permanent colostomy.
  • Pregnancy or planned pregnancy during the 12-month follow-up.
  • Severe uncontrolled systemic disease (e.g., decompensated heart failure, end-stage renal disease, uncontrolled diabetes).
  • Cognitive impairment or psychiatric disorder precluding reliable consent or questionnaire completion.
  • Lack of reliable contact information or inability to attend at least one scheduled follow-up visit.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

George Theodoropoulos contact

+30 213 208.8000

georgetheocrs@live.com

Greece1 site, 1 recruiting
  • Ippokrateio Hospital

    Athens

    George Theodoropoulos, +30 213 208.8000, georgetheocrs@live.com

    Recruiting

Other trials in Greece

About this study

Official title: Prospective Study of Functional Disorders and Quality of Life Following Surgical Management of Perianal Fistulas

Perianal fistulas are a chronic anorectal condition associated with significant morbidity, including pain, persistent discharge, infection, and impaired continence, all of which can substantially affect patients' quality of life. Surgical management aims to eradicate the fistulous tract while preserving anal sphincter function and continence.

Despite numerous available surgical techniques, high-quality comparative evidence regarding optimal management remains limited. This prospective observational study aims to evaluate clinical outcomes, functional outcomes, and patient-reported quality of life following surgical treatment of perianal fistulas.

The study will collect both clinician-reported and patient-reported outcomes over a 12-month follow-up period. Outcomes of interest include fistula healing, recurrence, postoperative complications, continence status, symptom burden, and health-related quality of life. The findings are expected to provide real-world data that may inform clinical decision-making and contribute to improved patient-centered care.

Read the detailed description

Background

Perianal fistulas are abnormal tracts that connect the anal canal or rectum to the perianal skin, most often developing after a perianal abscess that originates near the anal glands at the dentate line. The majority of fistulas arise secondary to an abscess. Treatment aims to eradicate the tract, prevent recurrence, and preserve continence by protecting the sphincter mechanism. Fistulas are classified anatomically (Parks) and, more clinically, as simple (low) or complex. Simple fistulas involve only the distal third of the external sphincter and are usually cured with sphincter-dividing procedures such as fistulotomy or fistulectomy, which have high healing rates and low continence risk. Complex fistulas-those that affect a larger portion of the sphincter, have multiple tracts, or are recurrent-require sphincter-preserving techniques (e.g., mucosal advancement flap, LIFT, laser treatment, plugs, or setons), although these approaches often carry higher recurrence rates. Current guidelines are hampered by limited high-quality evidence and marked heterogeneity in outcome definitions, measurement tools, and reporting practices, highlighting the need for standardized prospective data.

Study Objective and Design

The primary aim is to generate high-quality, real-world observational data on surgical management of perianal fistulas. The study will conduct a prospective cohort enrolling adult participants at the time of definitive fistula surgery and will follow them for 12 months. The cohort will be stratified by fistula complexity (simple vs. complex) and by surgical strategy (partially sphincter-dividing versus sphincter-preserving). The study will capture demographic, clinical, imaging, and operative information to explore how these variables relate to healing, recurrence, continence preservation, and patient-reported quality of life.

Data Collection and Analysis

Baseline data will include age, sex, comorbidities, pre-operative imaging, and any preceding seton placement or previous surgery. Operative details-type of technique, extent of sphincter involvement, intra-operative findings-will be recorded in a standardized case-report form. Follow-up assessments will occur at 1, 3, 6, and 12 months post-operatively and will collect clinician-reported endpoints (clinical and radiological healing, recurrence, complications graded by Clavien-Dindo) and patient-reported outcomes (continence status, symptom burden, health-related quality of life, psychological impact, and satisfaction) using validated instruments. Descriptive statistics will summarize patient and treatment characteristics; multivariable logistic and Cox regression models will evaluate associations between surgical approach, imaging findings, and outcomes, adjusting for confounders such as age, comorbidity, and fistula complexity. Subgroup analyses will compare outcomes across the two surgical strategy groups.

Anticipated Impact

By employing uniform outcome definitions and integrating both clinician- and patient-centered metrics, the study will fill a critical evidence gap regarding the comparative effectiveness of current fistula surgeries. The findings are expected to clarify which techniques achieve optimal healing while minimizing continence loss and to provide robust data that can refine clinical guidelines, inform shared-decision making, and ultimately improve functional and quality-of-life outcomes for patients with perianal fistulas.

Being tested
Perianal fistula surgical repair
Keywords
perianal, fistula, anal, PROMs, patient-reported outcomes, quality of life
Medical subject headings
Rectal Fistula, Fistula

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Perianal fistula surgical repairProcedure or surgery

    Patients undergo the operative procedure that their treating colorectal surgeon selects as routine clinical care for a primary or recurrent perianal fistula. The operative approach may be a sphincter-dividing technique (e.g., fistulotomy or fistulectomy) or a sphincter-preserving technique (e.g., ligation of the intersphincteric fistula tract [LIFT], mucosal advancement flap, laser fistula treatment, fistula plug, autologous biologic product injection, or seton placement). No investigational devices or experimental protocols are used; the study records the specific technique, intra-operative details, and any adjunctive measures (draining seton, pre-operative imaging, antibiotics, etc.) to allow comparison of real-world outcomes across all accepted surgical modalities for perianal fistulas.

Study groups in NCT07477496
Study groupRoleWhat they receive
Perianal-Fistula Surgical CohortAdults (≥ 18 y) undergoing any elective surgical repair for a primary or recurrent perianal fistula (simple or complex) in our center. All participants are followed prospectively for a minimum of 12 months with standardized clinician- and patient-reported outcome assessments.
Receives: Procedure: Perianal fistula surgical repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients with complete fistula healing (clinical examination)

    No clinically detectable perianal discharge, no signs of infection or inflammation, and no palpable/visible fistulous tract on physical examination.

    Measured: 1, 3, 6, 12 and 24 months

  2. Quality of Life (QoL)

    Anal Fistula Quality of Life (AF-QoL) questionnaire (0 = worst QoL, 100 = best QoL; higher scores indicate better health-related QoL)

    Measured: 1, 3, 6, 12 and 24 months

Secondary outcomes (7)
  1. Recurrence rate

    Re-appearance of any fistulous tract (clinical or imaging confirmation) after a documented period of ≥ 6months of complete healing, or identification of a new, distinct fistulous tract that was not present at baseline

    Measured: 12 and 24 months

  2. Incontinence symptoms

    Vaizey / St Mark's Incontinence Score (0 = perfect continence, 24 = complete incontinence)

    Measured: 1, 3, 6, 12 and 24 months

  3. Complications, Re-interventions, Readmission, Mortality

    Any adverse events (yes/no). Includes surgical site infection, wound dehiscence, bleeding, urinary retention. Any need for radiological or surgical re-intervention (yes/no), unplanned readmission (yes/no), or mortality (yes/no).

    Measured: 1, 3, 6, 12 and 24 months

  4. Clavien-Dindo classification of complications

    Complication, graded by Clavien-Dindo classification (I-V)

    Measured: 1, 3, 6, 12 and 24 months

  5. Patient satisfaction

    Numerical Rating Scale (NRS: 0-10; 0 indicating no pain, 10 worse pain)

    Measured: 1, 3, 6, 12 and 24 months

  6. EQ-5D-5L

    Quality of Life descriptive system comprising of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels (0: no problems, 5: severe problems)

    Measured: 1, 3, 6, 12 and 24 months

  7. EQ VAS

    The EQ VAS records the patient's self-rated health on a vertical visual analogue scale (0: worse health you can imagine and 100: best health you can imagine)

    Measured: 1, 3, 6, 12 and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2026
  2. Study start1 Jan 2026
  3. Primary completion1 Jan 2028 (estimated)
  4. Study completion1 Jan 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
24 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07477496
Sponsor's protocol ID
99/18-12-2025
Acronym
RAPPORT
Status last verified
Mar 2026
First submitted
11 Mar 2026
Last updated
19 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Anal Fistula Surgery and Anal Fistula, run by National and Kapodistrian University of Athens at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact George Theodoropoulos (+30 213 208.8000, georgetheocrs@live.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients with complete fistula healing (clinical examination) (time frame: 1, 3, 6, 12 and 24 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in